Osteopontin Modulates CD44-Dependent Chemotaxis of Peritoneal Macrophages Through G-Protein-Coupled Receptors: Evidence of a Role for an Intracellular Form of Osteopontin

Journal of Cellular Physiology

Volumn 198, Issue 1, 2004, Pages 155-167

  Zhu, Baoqian ^a   Suzuki, Keiko ^b   Goldberg, Harvey A ^c   Rittling, Susan R ^d   Denhardt, David T ^d   McCulloch, Christopher A G ^a   Sodek, Jaro ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b SHOWA UNIVERSITY   (Japan)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; G PROTEIN COUPLED RECEPTOR; HERMES ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; THROMBOSPONDIN; VITRONECTIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL FUSION; CELLULAR IMMUNITY; CHEMOTAXIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; IMMUNOPRECIPITATION; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; OSTEOCLAST; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE ACTIVATION;

ACTINS; ANIMALS; ANTIGENS, CD44; BIOLOGICAL MARKERS; CELL FUSION; CHEMOTAXIS; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; OSTEOCLASTS; OSTEOPONTIN; RECEPTORS, G-PROTEIN-COUPLED; SIALOGLYCOPROTEINS;

EID: 1642316557     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10394     Document Type: Article

References (57)

1. Ajuebor MN, Das AM, Virag L, Flower RJ, Szabo C, Perretti M. 1999. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: Evidence for an inhibitory loop involving endogenous IL-10. J Immunol 162:1685-1691.
2. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303-1313.
3. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, Rittling SR, Denhardt DT, Glimcher MJ, Cantor H. 2000. Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity. Science 287:860-8604.
4. Borland G, Ross JA, Guy K. 1998. Forms and functions of CD44. Immunology 93:139-148.
5. Boulay F, Naik N, Giannini E, Tardif M, Brouchon L. 1997. Phagocyte chemoattractant receptors. Ann N Y Acad Sci 832:69-84.
6. Butler WT, Ridall A, McKee MD. 1996. Osteopontin, In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. San Diego: Acad Press. pp 167-181.
7. Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M, Pedotti R, Heller R, Oksenberg JR, Steinman L. 2001. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease, Science 294:1731-1735.
8. Chellaiah M, Hruska K. 1996. Osteopontin stimulates gelsolin-associated phosphoinositide levels and phosphatidylinositol triphosphate-hydroxyl kinase. Mol Biol Cell 7:743-753.
9. Chellaiah MA, Biswas RS, Rittling SR, Denhardt DT, Hruska KA. 2003a. Rho-dependent Rho kinase activation increases CD44 surface expression and bone resorption in osteoclasts. J Biol Chem 278:29086-29097.
10. Chellaiah MA, Kizer N, Biswas R, Alvarez U, Strauss-Schoenberger J, Rifas L, Rittling SR, Denhardt DT, Hruska KA. 2003b. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Mol Biol Cell 14:173-189.
11. Denhardt DT, Noda M. 1998. Osteopontin expression and function: Role in bone remodeling. J Cell Biochem Suppl 31:92-102.
12. Denhardt DT, Giachelli CM, Rittling SR. 2001a. Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol 41:723-749.
13. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. 2001b. Osteopontin as a means to cope with environmental insults: Regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 107:1055-1061.
14. Ek-Rylander B, Flores M, Wendel M, Heinegard D, Andersson G. 1994. Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. J Biol Chem 269:14853-14856.
15. Entwistle J, Hall CL, Turley EA. 1996. HA receptors: Regulators of signaling to the cytoskeleton. J Cell Biochem 61:569-577.
16. Friedl P, Borgmann S, Brocker EB. 2001. Amoeboid leukocyte crawling through extracellular matrix: Lessons from the Dictyostelium paradigm of cell movement. J Leukoc Biol 70:491-509.
17. Giachelli CM, Steitz S. 2000. Osteopontin: A versatile regulator of inflammation and biomineralization. Matrix Biol 19:615-622.
18. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M. 1998. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152:353-358.
19. Goldberg HA, Sodek J. 1994. Purification of mineralized tissue-associated osteopontin. J Tissue Culture Meth 16:205-209.
20. Guo H, Cai CQ, Schroeder RA, Kuo PC. 2001. Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages. J Immunol 166:1079-1086.
21. Hamilton JA. 1997. CSF-1 signal transduction. J Leukoc Biol 62:145-155.
22. Jones GE. 2000. Cellular signalling in macrophage migration and chemotaxis. J Leukoc Biol 68:593-602.
23. Kasugai S, Zhang Q, Overall CM, Wrana JL, Butler WT, Sodek J. 1991. Differential regulation of the 55 and 44 kDa forms of secreted phosphoprotein 1 (SPP-1, osteopontin) in normal and transformed rat bone cells by osteotropic hormones, growth factors, and a tumor promoter. Bone Miner 13:235-250.
24. Katagiri YU, Sleeman J, Fujii H, Herrlich P, Hotta H, Tanaka K, Chikuma S, Yagita H, Okumura K, Murakami M, et al. 1999. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res 59:219-226.
25. Katayama Y, House CM, Udagawa N, Kazama JJ, McFarland RJ, Martin TJ, Findlay DM. 1998. Casein kinase 2 phosphorylation of recombinant rat osteopontin enhances adhesion of osteoclasts but not osteoblasts. J Cell Physiol 176:179-187.
26. Lin YH, Yang-Yen HF. 2001. The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. J Biol Chem 276:46024-46030.
27. Miyamoto A, Kunisada T, Hemmi H, Yamane T, Yasuda H, Miyake K, Yamazaki H, Hayashi SI. 1998. Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts. Biochem Biophys Res Commun 242:703-709.
28. Naot D, Sionov RV, Ish-Shalom D. 1997. CD44: Structure, function, and association with the malignant process. Adv Cancer Res 71:241-319.
29. Nau GJ, Liaw L, Chupp GL, Berman JS, Hogan BL, Young RA. 1999. Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin. Infect Immun 67:4223-4230.
30. Noiri E, Dickman K, Miller F, Romanov G, Romanov VI, Shaw R, Chambers AF, Rittling SR, Denhardt DT, Goligorsky MS. 1999. Reduced tolerance to acute renal ischemia in mice with a targeted disruption of the osteopontin gene. Kidney Int 56:74-82.
31. O'Regan A, Berman JS. 2000. Osteopontin: A key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol 81:373-390.
32. O'Regan AW, Chupp GL, Lowry JA, Goetschkes M, Mulligan N, Berman JS. 1999. Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. J Immunol 162:1024-1031.
33. O'Regan AW, Nau GJ, Chupp GL, Berman J. 2000. Osteopontin (Eta-1) in cell-mediated immunity: Teaching an old dog new tricks. Trends Immunol Today 21:475-478.
34. Oldberg A, Franzen A, Heinegard D. 1986. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 83:8819-8823.
35. Piper K, Boyde A, Jones SJ. 1992. The relationship between the number of nuclei of an osteoclast and its resorptive capability in vitro. Anat Embryol (Berl) 186:291-299.
36. Prince CW, Butler WT. 1987. 1,25-Dihydroxyvitamin D3 regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein, in clonal osteoblast-like osteosarcoma cells. Coll Relat Res 7:305-313.
37. Puré E, Cuff CA. 2001. A crucial role for CD44 in inflammation. Trends Mol Med 7:213-221.
38. Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE, Kowalski AJ, Noda M, Denhardt DT. 1998. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 13:1101-1111.
39. Ross FP, Chappel J, Alvarez JI, Sander D, Butler WT, Farach-Carson MC, Mintz KA, Robey PG, Teitelbaum SL, Cheresh DA. 1993. Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. J Biol Chem 268:9901-9907.
40. Saleem A, Kharbanda S, Yuan ZM, Kufe D. 1995. Monocyte colony-stimulating factor stimulates binding of phosphatidylinositol 3-kinase to Grb2.Sos complexes in human monocytes. J Biol Chem 270:10380-10383.
41. Schmits R, Filmus J, Gerwin N, Senaldi G, Kiefer F, Kundig T, Wakeham A, Shahinian A, Catzavelos C, Rak J, et al. 1997. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 90:2217-2233.
42. Senger DR, Perruzzi CA, Papadopoulos A, Tenen DG. 1989. Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin. Biochim Biophys Acta 996:43-48.
43. Smith LL, Greenfield BW, Aruffo A, Giachelli CM. 1999. CD44 is not an adhesive receptor for osteopontin. J Cell Biochem 73:20-30.
44. Sodek J, Ganss B, McKee MD. 2000, Osteopontin. Crit Rev Oral Biol Med 11:279-303.
45. Sodek J, Zhu B, Huynh M-H, Brown TJ, Ringuette M. 2002. Novel functions of the matricellular proteins osteopontin and osteonectin/SPARC. Connect Tiss Res 43:308-319.
46. Suzuki K, Zhu B, Rittling SR, Denhardt DT, Goldberg HA, McCulloch CAG, Sodek J. 2002. Co-localization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts. J Bone Miner Res 17:1486-1497.
47. Takeshita S, Kaji K, Kudo A. 2000. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res 15:1477-1488.
48. Trueblood NA, Xie Z, Communal C, Sam F, Ngoy S, Liaw L, Jenkins AW, Wang J, Sawyer DB, Bing OH, Apstein CS, Colucci WS, Singh K. 2001. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ Res 88:1080-1087.
49. Tsukita S, Yonemura S. 1997. ERM proteins: Head-to-tail regulation of actin-plasma membrane interaction. Trends Biochem Sci 22:53-58.
50. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A. 1994. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 126:391-401.
51. Weber GF, Ashkar S, Glimcher MJ, Cantor H. 1996. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509-512.
52. Weintraub AS, Schnapp LM, Lin X, Taubman MB. 2000. Osteopontin deficiency in rat vascular smooth muscle cells is associated with an inability to adhere to collagen and increased apoptosis. Lab Invest 80:1603-1615.
53. Yamazaki M, Nakajima F, Ogasawara A, Moriya H, Majeska RJ, Einhorn TA. 1999. Spatial and temporal distribution of CD44 and osteopontin in fracture callus. J Bone Joint Surg Br 811:508-515.
54. Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, Nifuji A, Uede T, Denhardt DT, Noda M. 2002. Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc Natl Acad Sci USA 99:4556-4561.
55. Zhang Q, Domenicucci C, Goldberg HA, Wrana JL, Sodek J. 1990. Characterization of fetal porcine bone sialoproteins, secreted phosphoprotein I (SPPI, osteopontin), bone sialoprotein, and a 23-kDa glycoprotein. Demonstration that the 23-kDa glycoprotein is derived from the carboxyl terminus of SPPI. J Biol Chem 265:7583-7589.
56. Zhu XL, Ganss B, Goldberg HA, Sodek J. 2001. Synthesis and processing of bone sialoproteins during de novo bone formation in vitro. Biochem Cell Biol 79:737-746.
57. Zohar R, Suzuki N, Suzuki K, Arora P, Glogauer M, McCulloch CAG, Sodek J. 2000. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J Cell Physiol 184:118-130.